Market Insight

Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, evaluating the impact of early mechanical thrombectomy in patients with intermediate-risk pulmonary embolism (PE).
The analysis compared patients treated with the Symphony thrombectomy system within 12 hours of di

VahatiCor has enrolled the first U.S. patient in its SERRA-I early feasibility study, evaluating the investigational A-FLUX Reducer System® for patients with coronary microvascular dysfunction (CMD).
The study, conducted in the U.S. and Europe, is assessing the safety and initial performance of the c

FiberSense has received CE mark approval for its continuous glucose monitoring (CGM) system, allowing the company to move toward commercialization in selected European markets.
The CGM uses optical sensing technology to continuously measure glucose levels in interstitial fluid for adults with diabete

A strong signal of execution across the sector this week, with MedTech companies raising capital to accelerate commercialization, expand clinical adoption, and strengthen U.S. market presence.
Nyxoah secures $110M financing to accelerate U.S. launch of Genio
The financing includes $95M in equity fundi

AngioDynamics has received FDA investigational device exemption (IDE) approval to begin the RELIEF feasibility study, evaluating its NanoKnife system for treating lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH).
NanoKnife uses irreversible electroporation (IRE), a tec

Sonire Therapeutics has been awarded a $13 million grant from Japan’s New Energy and Industrial Technology Development Organization (NEDO) to accelerate development of its Suizenji ultrasound-based treatment system for pancreatic cancer.
The funding comes through NEDO’s Deep-Tech Startups Support (DT

Icarus Medical has secured an oversubscribed $7.2 million Series A financing round to accelerate commercialization and development of its orthopedic bracing technologies.
The Charlottesville-based medtech company develops advanced braces using biomechanics, additive manufacturing, and patient-focused

Italian medtech company WISE has closed an oversubscribed €30 million ($34.8 million) Series D financing round to accelerate development and clinical adoption of its Heron spinal cord stimulation (SCS) system for chronic pain treatment.
The funding, which included participation from ENEA Tech and Bio

Distalmotion has received FDA 510(k) clearance to expand the use of its Dexter surgical robot across additional gynecologic procedures, including sacrocolpopexy, sacrocervicopexy, sacrohysteropexy, and endometriosis resection.
The approval marks Dexter’s second gynecology clearance and expands its in